All In Biotech

Drug Trial Radar · NCT04049591

Higher vs. Lower Dose Heparin for PCI

A Randomized Trial of Higher vs. Lower Dose Heparin for PCI

Last checked: Nov 19, 2026Latest source record: Jul 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 16,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

16,000

Planned (sponsor's estimate)

Start

Mar 2, 2022

Primary completion

Oct 8, 2024

Study completion Dec 2025

Sponsor

Lead sponsor
Population Health Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 8, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).

Conditions

  • Cardiovascular Diseases
  • Percutaneous Coronary Intervention

Interventions

  • Higher Dose UFHDrug

    Centre wide policy of administering 100 U/kg bolus of intravenous UFH for elective PCI procedures

  • Lower Dose UFHDrug

    Centre wide policy of administering 70 U/kg bolus of intravenous UFH for elective PCI procedures

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with any of the following: death, myocardial infarction or target vessel revascularizationTime frame: up to 30 days after PCI

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hamilton Health Sciences, General Hospital

    Hamilton, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.